Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

81.71
Delayed Data
As of Aug 15
 +0.22 / +0.27%
Today’s Change
64.18
Today|||52-Week Range
86.72
+11.09%
Year-to-Date
LLY Regular Dividend: LLY began trading ex-dividend on 08/11/17. A $0.52 dividend will be paid to shareholders of record as of 08/15/17.

Today’s Trading

Previous close81.49
Today’s open81.50
Day’s range81.50 - 82.34
Volume1,949,478
Average volume (3 months)3,761,028
Market cap$90.0B
Dividend yield2.55%
Data as of 08/15/2017

Growth & Valuation

Earnings growth (last year)+14.16%
Earnings growth (this year)+18.16%
Earnings growth (next 5 years)+12.80%
Revenue growth (last year)+6.33%
P/E ratio35.4
Price/Sales3.68
Price/Book6.42

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.18+0.40%
BMYBristol-Myers Squibb+0.25+0.43%
ABTAbbott Laboratories-0.26-0.53%
GSKGlaxoSmithKline-0.06-0.15%
Data as of 9:20am ET, 08/16/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$1.03
Annual revenue (last year)$21.2B
Annual profit (last year)$2.7B
Net profit margin12.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts